Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Americans are living longer for many reasons and experts credit Medicare and Medicaid for some…
“I would have never, ever in my whole life have said, ‘we’re going to cure…
Dr. Betancourt, president of the influential The Commonwealth Fund, is committed to “Affordable, quality health…
President Trump signed the “One Big Beautiful Bill Act” into law on July 4 and…
ENCORE - Originally aired November 7, 2024 There’s a lot of attention right now around…
Originally broadcast May 15, 2025 Millions are still living with the effects of Long COVID…